Strides gets USFDA nod for anti-allergic drug

Strides gets USFDA nod for anti-allergic drug In a filing to BSE Strides said its "step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received approval for Loratadine Softgel Capsules, 10 mg (OTC) from the United States Food Drug Administration (USFDA)."

No comments:

Post a Comment